Country: United States
Language: English
Source: NLM (National Library of Medicine)
NORETHINDRONE ACETATE (UNII: 9S44LIC7OJ) (NORETHINDRONE - UNII:T18F433X4S), ETHINYL ESTRADIOL (UNII: 423D2T571U) (ETHINYL ESTRADIOL - UNII:423D2T571U)
Glenmark Pharmaceuticals Inc., USA
PRESCRIPTION DRUG
Norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules are indicated for use by females of reproductive age to prevent pregnancy [see Clinical Studies (14)] . The efficacy of norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules in women with a body mass index (BMI) of more than 35 kg/m2 has not been evaluated. Norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules are contraindicated in females who are known to have or develop the following conditions: Risk Summary Risk Summary Contraceptive hormones and/or metabolites are present in human milk. COCs can reduce milk production in breastfeeding females. This reduction can occur at any time but is less likely to occur once breastfeeding is well-established. When possible, advise the nursing female to use other methods of contraception until she discontinues breastfeeding [see Dosage and Administration ( 2.2)] . The developmental and health benefits of breastfeeding should be
Norethindrone Acetate and Ethinyl Estradiol Capsules and Ferrous Fumarate Capsules are available in blisters (dispensers) containing 28 soft gelatin capsules: Each blister contains 28 capsules in the following order: Each blister is packed in a carton (NDC 68462-849-84). Cartons of 3 blisters packed individually in 3 cartons are provided for dispensing (NDC 68462-849-29). 3 cartons - each carton contains 1 blister (28): NDC 68462-849-84. Store at 25ºC (77ºF); excursions permitted to 15°C to 30ºC (59°F to 86ºF) [see USP Controlled Room Temperature].
Abbreviated New Drug Application
NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE- NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE GLENMARK PHARMACEUTICALS INC., USA ---------- HIGHLIGHTS OF PRESCRIBING INFORMATION THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL CAPSULES AND FERROUS FUMARATE CAPSULES SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL CAPSULES AND FERROUS FUMARATE CAPSULES. NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL CAPSULES AND FERROUS FUMARATE CAPSULES, FOR ORAL USE INITIAL U.S. APPROVAL: 1968 WARNING: CIGARETTE SMOKING AND SERIOUS CARDIOVASCULAR EVENTS _SEE FULL PRESCRIBING INFORMATION FOR COMPLETE BOXED WARNING._ • • INDICATIONS AND USAGE • • DOSAGE AND ADMINISTRATION • • • DOSAGE FORMS AND STRENGTHS Norethindrone Acetate and Ethinyl Estradiol Capsules and Ferrous Fumarate Capsules consists of 28 soft gelatin capsules in the following order (3): (3) • • CONTRAINDICATIONS • • • • • WARNINGS AND PRECAUTIONS • WOMEN OVER 35 YEARS OLD WHO SMOKE SHOULD NOT USE NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL CAPSULES AND FERROUS FUMARATE CAPSULES. (4) CIGARETTE SMOKING INCREASES THE RISK OF SERIOUS CARDIOVASCULAR EVENTS FROM COMBINATION ORAL CONTRACEPTIVE (COC) USE. (4) Norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules are a combination of norethindrone acetate, a progestin, and ethinyl estradiol, an estrogen, indicated for use by females of reproductive potential to prevent pregnancy (1) The efficacy of norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules in females of reproductive potential with a body mass index (BMI) of > 35 kg/m has not been evaluated (1, 8.8) 2 Take one capsule by mouth at the same time every day (2.1) Take capsules in the order directed on the blister pack (2.1) Capsules may be administered without regard to meals (2.1) 24 pink capsules (active), each containing 1 mg noreth Read the complete document